Peroxisome proliferator-activated receptors in inflammation control.

By P. Delerive, J. Fruchart, Bart Staels. Journal of Endocrinology, 2001

796 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/ae29a03378d36b31261d2d29ceda2b55aa46db77

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. M. Laplante
2. David M. Sabatini

In Molecular Biology

1. S. Kersten
2. D. Cohen
3. Y. Kawano
4. M. Laplante
5. David M. Sabatini

Citations in the corpus

• Emerging roles of PPARS in inflammation and immunity (2002, background): “Most of the anti-inflammatory properties that have been ascribed to glucocorticoids result from the ability of activated GRs to transrepress the enhancing effects on inflammatory gene expression of other transcription factors — such as AP1, NF-κB, STATs and NFAT — in a DNA-independent manne”
• Peroxisome Proliferator-Activated Receptor Alpha Target Genes (2010, background): “Specifically, it has been shown that activated PPARα binds to c-Jun and to the p65 subunit of NF-κB, thereby inhibiting AP-1- and NF-κB- mediated signaling [248].”